PALM SPRINGS, Calif. (KESQ) - A break-in at Alcorn Adaptive Bikes has left owner Jerry Alcorn and his family facing emotional and financial hardship as they work to recover from the damage and losses.

Short on time? View a quick summary of this article in the video below: As the availability of ChatGPT Search expands, understanding its indexing mechanics will be vital for digital visibility. While ...

The American Heart Association’s 2025 Adult Basic Life Support Guidelines build upon prior versions with updated recommendations for assessment and management of persons with cardiac arrest, as well ...

Anthropic today launched Claude Design, a new AI product for creating designs, prototypes, slides, and more. Claude Design uses Opus 4.7, a new AI model that was introduced earlier this week. Opus 4.7 ...

Anthropic announced on Friday that it’s launching Claude Design, a new experimental product that lets users create visuals like prototypes, slides, one-pagers, and more using Claude. The company says ...

It’s easy to get caught up in all the details of strength training: how exactly to fit it into your run schedule, the ideal number of reps and sets to do to see results, and the perfect moves to ...

Guidelines for Creating the *Chauki* (Altar) in Chaitra Navratri: This year, Chaitra Navratri commences on March 19, 2026. Over these nine days dedicated to honoring *Shakti* (the Divine Feminine), ...

Debuting at SXSW, the comedy follows a young woman who, in the wake of a devastating break-up, becomes increasingly fixated on her ex-boyfriend's ex-girlfriend. By Angie Han Television Critic There ...

Claude Code and Nano Banana 2 are platforms designed to support website design by combining functionality and ease of use. As explored by Jack Roberts, these platforms offer features like responsive ...

The Dietary Guidelines for Americans (DGA)—issued by the U.S. Department of Agriculture (USDA) and the Department of Health and Human Services (HHS)—shape federal food programs and nutrition messaging ...

Besremi is now a Category 1 preferred treatment for high-risk ET patients with inadequate response to existing therapies, according to NCCN guidelines. The NCCN's inclusion of Besremi reflects strong ...